Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",0.0021163088591055553,6.48,39.90437014161272,"['NPFFR1', 'NPY1R', 'OPRK1', 'OR6A2', 'ADRA2A']",0.11708279804696874,0,0,5
2,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.002890933285110339,62.92307692307692,367.8593754189421,"['YAP1', 'FERMT3']",0.11708279804696874,0,0,2
3,MECP2 and Associated Rett Syndrome WP3584,0.013586682020463764,15.711538461538462,67.53864408236899,"['GABRR2', 'OPRK1']",0.30187977762947565,0,0,2
4,Mesodermal commitment pathway WP2857,0.018634554174658993,12.564102564102564,50.03952457710967,"['YAP1', 'SLC2A12']",0.30187977762947565,0,0,2
5,DNA IR-double strand breaks and cellular response via ATM WP3959,0.018634554174658993,12.564102564102564,50.03952457710967,"['YAP1', 'BRCA1']",0.30187977762947565,0,0,2
6,Serotonin Transporter Activity WP1455,0.03155800567766904,inf,inf,['IL1R1'],0.3231300651771385,0,0,1
7,Cytosine methylation WP3585,0.03155800567766904,inf,inf,['TDG'],0.3231300651771385,0,0,1
8,Prader-Willi and Angelman Syndrome WP3998,0.037555627339944046,7.842948717948718,25.740024759381914,"['GABRR2', 'SNURF']",0.3231300651771385,0,0,2
9,Peptide GPCRs WP24,0.04497694886179518,6.968660968660969,21.614034874237074,"['NPY1R', 'OPRK1']",0.3231300651771385,0,0,2
10,TGF-beta Signaling Pathway WP366,0.06125169247281609,5.696969696969697,15.910290726460797,"['YAP1', 'ETS1']",0.3231300651771385,0,0,2
11,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.062132262438806075,31.063291139240505,86.30904072140198,['HOMER1'],0.3231300651771385,0,0,1
12,Fluoropyrimidine Activity WP1601,0.062132262438806075,31.063291139240505,86.30904072140198,['TDG'],0.3231300651771385,0,0,1
13,Gastric Cancer Network 2 WP2363,0.062132262438806075,31.063291139240505,86.30904072140198,['SNURF'],0.3231300651771385,0,0,1
14,miR-509-3p alteration of YAP1/ECM axis WP3967,0.062132262438806075,31.063291139240505,86.30904072140198,['YAP1'],0.3231300651771385,0,0,1
15,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.062132262438806075,31.063291139240505,86.30904072140198,['LTBP1'],0.3231300651771385,0,0,1
16,DNA Repair Pathways Full Network WP4946,0.07003200098887445,5.22008547008547,13.87917882675562,"['TDG', 'BRCA1']",0.3231300651771385,0,0,2
17,IL-1 signaling pathway WP195,0.09175298147005166,15.525316455696203,37.08462938932974,['IL1R1'],0.3231300651771385,0,0,1
18,EDA signaling in hair follicle development WP3930,0.09175298147005166,15.525316455696203,37.08462938932974,['SOSTDC1'],0.3231300651771385,0,0,1
19,IL1 and megakaryocytes in obesity WP2865,0.09175298147005166,15.525316455696203,37.08462938932974,['IL1R1'],0.3231300651771385,0,0,1
20,Signal transduction through IL1R WP4496,0.09175298147005166,15.525316455696203,37.08462938932974,['IL1R1'],0.3231300651771385,0,0,1
21,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.09175298147005166,15.525316455696203,37.08462938932974,['IL1R1'],0.3231300651771385,0,0,1
22,Monoamine Transport WP727,0.09175298147005166,15.525316455696203,37.08462938932974,['IL1R1'],0.3231300651771385,0,0,1
23,Disruption of postsynaptic signaling by CNV WP4875,0.09175298147005166,15.525316455696203,37.08462938932974,['HOMER1'],0.3231300651771385,0,0,1
24,Netrin-UNC5B signaling pathway WP4747,0.12044952450394741,10.345991561181435,21.897544591124912,['YAP1'],0.33271918415469803,0,0,1
25,Fatty acid beta-oxidation WP143,0.12044952450394741,10.345991561181435,21.897544591124912,['CPT1B'],0.33271918415469803,0,0,1
26,BDNF-TrkB Signaling WP3676,0.12044952450394741,10.345991561181435,21.897544591124912,['HOMER1'],0.33271918415469803,0,0,1
27,Major receptors targeted by epinephrine and norepinephrine WP4589,0.12044952450394741,10.345991561181435,21.897544591124912,['ADRA2A'],0.33271918415469803,0,0,1
28,"GPCRs, Class B Secretin-like WP334",0.12044952450394741,10.345991561181435,21.897544591124912,['CALCR'],0.33271918415469803,0,0,1
29,RANKL/RANK signaling pathway WP2018,0.12044952450394741,10.345991561181435,21.897544591124912,['CALCR'],0.33271918415469803,0,0,1
30,Integrated breast cancer pathway WP1984,0.12968096428528203,3.4715099715099713,7.09117692650972,"['DCAKD', 'BRCA1']",0.33271918415469803,0,0,2
31,Imatinib and Chronic Myeloid Leukemia WP3640,0.14825036831377147,7.756329113924051,14.805690210966713,['SPRED2'],0.33271918415469803,0,0,1
32,Endothelin Pathways WP2197,0.14825036831377147,7.756329113924051,14.805690210966713,['NPY1R'],0.33271918415469803,0,0,1
33,ATM Signaling Pathway WP2516,0.14825036831377147,7.756329113924051,14.805690210966713,['BRCA1'],0.33271918415469803,0,0,1
34,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.14825036831377147,7.756329113924051,14.805690210966713,['IGFBP5'],0.33271918415469803,0,0,1
35,Integrated Cancer Pathway WP1971,0.17518312533896924,6.2025316455696204,10.804335147110372,['BRCA1'],0.33271918415469803,0,0,1
36,Pathways affected in adenoid cystic carcinoma WP3651,0.17518312533896924,6.2025316455696204,10.804335147110372,['BRCA1'],0.33271918415469803,0,0,1
37,MET in type 1 papillary renal cell carcinoma WP4205,0.17518312533896924,6.2025316455696204,10.804335147110372,['ETS1'],0.33271918415469803,0,0,1
38,DNA IR-damage and cellular response via ATR WP4016,0.17518312533896924,6.2025316455696204,10.804335147110372,['BRCA1'],0.33271918415469803,0,0,1
39,Hypertrophy Model WP516,0.17518312533896924,6.2025316455696204,10.804335147110372,['IL1R1'],0.33271918415469803,0,0,1
40,Vitamin D Receptor Pathway WP2877,0.19711086006388112,2.5972222222222223,4.21786023395094,"['IGFBP5', 'SOSTDC1']",0.33271918415469803,0,0,2
41,DNA Replication WP466,0.20127456819234818,5.166666666666667,8.282607342826527,['GMNN'],0.33271918415469803,0,0,1
42,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.20127456819234818,5.166666666666667,8.282607342826527,['ETS1'],0.33271918415469803,0,0,1
43,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.20127456819234818,5.166666666666667,8.282607342826527,['LTBP1'],0.33271918415469803,0,0,1
44,TGF-beta Receptor Signaling WP560,0.20127456819234818,5.166666666666667,8.282607342826527,['LTBP1'],0.33271918415469803,0,0,1
45,Thermogenesis WP4321,0.20127456819234818,5.166666666666667,8.282607342826527,['CPT1B'],0.33271918415469803,0,0,1
46,Fragile X Syndrome  WP4549,0.20127456819234818,5.166666666666667,8.282607342826527,['HOMER1'],0.33271918415469803,0,0,1
47,Galanin receptor pathway WP4970,0.20127456819234818,5.166666666666667,8.282607342826527,['YAP1'],0.33271918415469803,0,0,1
48,PPAR signaling pathway WP3942,0.20127456819234818,5.166666666666667,8.282607342826527,['CPT1B'],0.33271918415469803,0,0,1
49,Hepatitis C and Hepatocellular Carcinoma WP3646,0.20127456819234818,5.166666666666667,8.282607342826527,['BRCA1'],0.33271918415469803,0,0,1
50,Base Excision Repair WP4752,0.22655065452079146,4.426763110307414,6.572799073433484,['TDG'],0.3462377927581907,0,0,1
51,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.22655065452079146,4.426763110307414,6.572799073433484,['MAPKAPK3'],0.3462377927581907,0,0,1
52,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.22655065452079146,4.426763110307414,6.572799073433484,['YAP1'],0.3462377927581907,0,0,1
53,Monoamine GPCRs WP58,0.22655065452079146,4.426763110307414,6.572799073433484,['ADRA2A'],0.3462377927581907,0,0,1
54,MAPK Signaling Pathway WP382,0.2322881263842597,2.3057929724596393,3.365942980261678,"['MAPKAPK3', 'IL1R1']",0.34843218957638955,0,0,2
55,Neural Crest Differentiation WP2064,0.2510365511923774,3.8718354430379747,5.351483407969212,['ETS1'],0.35058552838935464,0,0,1
56,AMP-activated protein kinase (AMPK) signaling WP1403,0.2510365511923774,3.8718354430379747,5.351483407969212,['CPT1B'],0.35058552838935464,0,0,1
57,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.2510365511923774,3.8718354430379747,5.351483407969212,['ETS1'],0.35058552838935464,0,0,1
58,Fas ligand pathway and stress induction of heat shock proteins WP314,0.2510365511923774,3.8718354430379747,5.351483407969212,['MAPKAPK3'],0.35058552838935464,0,0,1
59,Endoderm differentiation WP2853,0.2977346311715531,3.0949367088607596,3.7496788907636702,['SLC2A12'],0.3868576981344384,0,0,1
60,Melanoma WP4685,0.2977346311715531,3.0949367088607596,3.7496788907636702,['ETS1'],0.3868576981344384,0,0,1
61,Glioblastoma signaling pathways WP2261,0.2977346311715531,3.0949367088607596,3.7496788907636702,['BRCA1'],0.3868576981344384,0,0,1
62,Apoptosis Modulation and Signaling WP1772,0.31999340462972065,2.8124280782508633,3.2046349375972127,['IL1R1'],0.3868576981344384,0,0,1
63,B Cell Receptor Signaling Pathway WP23,0.31999340462972065,2.8124280782508633,3.2046349375972127,['ETS1'],0.3868576981344384,0,0,1
64,TYROBP causal network in microglia WP3945,0.31999340462972065,2.8124280782508633,3.2046349375972127,['LOXL3'],0.3868576981344384,0,0,1
65,Ciliopathies WP4803,0.31999340462972065,2.8124280782508633,3.2046349375972127,['AK7'],0.3868576981344384,0,0,1
66,miRNA regulation of DNA damage response WP1530,0.31999340462972065,2.8124280782508633,3.2046349375972127,['BRCA1'],0.3868576981344384,0,0,1
67,DNA damage response WP707,0.31999340462972065,2.8124280782508633,3.2046349375972127,['BRCA1'],0.3868576981344384,0,0,1
68,16p11.2 proximal deletion syndrome WP4949,0.3415552128326755,2.577004219409283,2.7683363088223722,['KCTD13'],0.4068525329330399,0,0,1
69,Androgen receptor signaling pathway WP138,0.3826734975099804,2.2070524412296564,2.1200352942659917,['BRCA1'],0.44922541012041184,0,0,1
70,Ciliary landscape WP4352,0.42125414770997277,1.9295886075949367,1.668165919224194,['YAP1'],0.4874512280643971,0,0,1
71,Ras signaling WP4223,0.4396415900820708,1.8153387937453462,1.49183716454981,['ETS1'],0.5015629407978555,0,0,1
72,Spinal Cord Injury WP2431,0.47470300921672054,1.6229180546302464,1.2091809241229268,['IL1R1'],0.5340408853688106,0,0,1
73,Senescence and Autophagy in Cancer WP615,0.5075963623589367,1.467148884870404,0.9948277510394479,['IGFBP5'],0.5556122344739712,0,0,1
74,NRF2 pathway WP2884,0.5075963623589367,1.467148884870404,0.9948277510394479,['SLC2A12'],0.5556122344739712,0,0,1
75,Breast cancer pathway WP4262,0.5384541215000801,1.3384700055035774,0.8285838493730668,['BRCA1'],0.5738787347566644,0,0,1
76,Circadian rhythm related genes WP3594,0.5384541215000801,1.3384700055035774,0.8285838493730668,['HOMER1'],0.5738787347566644,0,0,1
77,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5531588509627716,1.2821729957805907,0.7591875366573723,['CDCA7L'],0.5744341913844168,0,0,1
78,Myometrial relaxation and contraction pathways WP289,0.5531588509627716,1.2821729957805907,0.7591875366573723,['IGFBP5'],0.5744341913844168,0,0,1
79,VEGFA-VEGFR2 Signaling Pathway WP3888,0.6323874801996754,0.9428007889546351,0.4320412627160457,"['ETS1', 'SLC25A25']",0.6483972898249836,0,0,2
80,PI3K-Akt signaling pathway WP4172,0.7343019120800015,0.7642405063291139,0.23602422485676253,['BRCA1'],0.7434806859810015,0,0,1
81,Nuclear Receptors Meta-Pathway WP2882,0.7742981321015261,0.6779184247538678,0.17341037785386806,['SLC2A12'],0.7742981321015261,0,0,1
